维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="LEGGAS M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Progesterone acts via progesterone receptots A and B to regulate breast cancer resistance protein expression显示文摘	Vore M Leggas M	2008	Mol Pharmacol2008，23，3：	1
2	Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice显示文摘	Assem M Schuetz EG Leggas M Sun D Yasuda K Reid G	2004	J Biol Chem2004，279，22：	1
3	Abrogation ofmicrocystin cytotoxicity by MAP kinase inhibitors and N -acetyl cysteine is confounded by OATP1B1 uptake activityinhibition 显示文摘	DAILY A MONKS N R LEGGAS M	2009	Toxicon2009，55，4：	1
4	Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy显示文摘	Leggas M Adachi M Scheffer G L	2004	Molecular and Cellular Biology2004，24，17：	1
5	Mrp4 confers resistance to topotecan and protects the brain from chemotherapy显示文摘	LEGGAS M ADACHI M SCHEFFER GL	2004	Mol Cell Biol2004，24，17：	1
6	Relation between Irofulven (MG1-114) systemic exposure and tumor response in human solid tumor xenografts 显示文摘	Leggas M Stewart CF Woo MH	2002	Clin Cancer Res2002，8，9：	1
7	Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors显示文摘	Adams VR Leggas M	2007	Clin Ther2007，29，7：	1
8	MRP4 confers resistance to topoteean andprotects the brain from chemotherapy 显示文摘	Leggas M Adachi M Scheffer GL	2004	Mol Cell Biol2004，24，17：	1
9	Localization and functional characterization of the rat Oatp4c1 transporter in an in vitro cell system and rat tissues显示文摘	Kuo KL Zhu H McNamara PJ Leggas M	2012	PLoS One2012，7，39：	1
10	Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo 显示文摘	Leggas M Panetta JC Zhuang Y	2006	Cancer Res2006，66，：	1
11	Simvastatin interacts syn- ergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition 显示文摘	Ahmed TA Hayslip J Leggas M	2014	Leuk Res2014，38，11：	1
12	Interactions be- tween hepatic Mrp4 and Sult2a as revealed by the constitu- tive androstane receptor and Mrp4 knockout mice 显示文摘	Assem M Schuetz EG Leggas M	2004	J Biol Chem2004，279，22：	1
13	Relation between Iroful- ven (MGI-114) Systemic Exposure and Tumor Response in Human Solid Tumor Xenografts显示文摘	Leggas M Stewart C F Woo M H	2002	Clinical Cancer Research2002，，8：	1
14	Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice显示文摘	Stewart CF Leggas M Schuetz JD		0，，20：	1
15	MRP4 confers resistance to topotecan protects the brain from chemotherapy显示文摘	Leggas M Adachi M Scheffer GL	2004	Molecular Cellular Biology2004，24，17：	1
16	MRP4 confers resistance to topotecan and protects the brain from chemotherapy 显示文摘	Leggas M Adachi M Scheffer GL	2004	Mol Cell Biol2004，24，：	1
17	Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibition显示文摘	Daily A Monks N R Leggas M	2009	Toxicon2009，55，：	1
18	Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal rumors 显示文摘	Adams VR Leggas M	2007	Clin Ther2007，29，7：	1
19	Microbore HPLC method with online microdialysis for measurement of topotecan lactone and carboxylate in murine CSF显示文摘	Leggas M Zhuang YL Welden J	2004	Journal of pharmaceutical sciences2004，93，9：	1
20	Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice显示文摘	STEWART CF LEGGAS M SCHUETZ JD et ol	2004	Cancer Res2004，64，20：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示